Danville, PA2 Active Studies

Interstitial Lung Disease Clinical Trials in Danville, PA

Find 2 actively recruiting interstitial lung disease clinical trials in Danville, PA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,684
Enrolling

Recruiting Interstitial Lung Disease Studies in Danville

About Interstitial Lung Disease Clinical Trials in Danville

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 2 interstitial lung disease clinical trials recruiting participants in Danville, PA. These studies are seeking a combined 1,684 participants. Research is being sponsored by Johns Hopkins University, National Institute of Mental Health (NIMH). Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Danville — FAQ

Are there interstitial lung disease clinical trials in Danville?

Yes, there are 2 interstitial lung disease clinical trials currently recruiting in Danville, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Danville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Danville research site will contact you about next steps.

Are clinical trials in Danville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Danville studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 2 active trials in Danville are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov